Cardioprotective Effects of Phosphocreatine in Vascular Surgery

Abstract

The pharmacologic use of phosphocreatine (Pcr) in cardiology and cardiac surgery, along with other so-called metabolic drugs, to prevent the ultrastructural and clinical effects of ischemia on the myocardium has been the aim of many studies during recent years.

To evaluate the protective action of Pcr in a series of surgical vascular patients with an associated heart disease, the authors have included in this study 62 patients undergoing vascular operations and have randomly divided them into a Pcr-treated group and a control group.

The cardiac index (L x min-1 x m-2), the use of inotropic drugs (number of patients), the EKG alterations (ST ≥ 2 mm, arrhythmias) with a Holter registration, and the measurement of ejection fraction by 2D-Echo Doppler analysis were examined.

A statistically significant improvement in the central hemodynamics during the immediate postoperative course was observed in the Pcr group, preserving a good left ventricular function and preventing severe arrhythmias. The results revealed that the use of Pcr induced a more efficacious protection of the myocardium with an improved functional recovery, a positive inotropic effect, and an antiarrhythmic action. Nevertheless there is need for further studies to demonstrate the real benefit of using Pcr for myocardial protection in vascular surgery.

Get full access to this article

View all access options for this article.

References

1. Saks VA , Rosentrankh LV , Smirnov VN , et al: Role of creatine phosphokinase in cellular function and metabolism. Can J Physiol Pharmacol 56:691-706, 1978.

2. Sharov VG , Saks VA , Kupriyanov VV , et al: Protection of ischemic myocardium by exogenous phosphocreatine. I. Morphological and phosphorus 31-nuclear magnetic resonance studies. J Thorac Cardiovasc Surg 94:749-761, 1987.

3. Mastroroberto P , Di Tommaso L , Chello M , et al: Creatine phosphate protection of the ischemic myocardium during cardiac surgery. Curr Ther Res 51:37-45, 1992.

4. Fagbemi O , Kane KA , Parrat JR : Creatine phosphate suppresses ventricular arrhythmias resulting from coronary artery ligation. J Cardiovasc Pharmacol 4:53-58, 1982.

5. Sharov VG : Protection of ischemic myocardium by exogenous phosphocreatine: Pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic cardiomyocytes and antithrombotic action. Biochem Med Metab Biol 35:101-114, 1986.

6. Halliwell B , Gutteridge JMC : Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219:1-14, 1984.

7. Noronha-Dutra AA , Stem EM : Lipid peroxidation as a mechanism of injury in cardiac myocytes. Lab Invest 47:346-353, 1982.

8. Ambrosio G , Weisfeldt ML , Jacobus WE , et al: Evidence for a reversible oxygen radical-mediated component of reperfusion-injury: Reduction by recombinant superoxide dismutase administered at the time of reflow. Circulation 75:282-291, 1987.

9. Abbott WM , Maloney RD , McCabe CC : Arterial embolism: A 44 year perspective. Am J Surg 143:460-464, 1982.

10.

10. Haimovici H : Muscular renal and metabolic complication of acute arterial occlusions: Myonephropathic-metabolic syndrome. Surgery 85:461-468, 1979.

11.

11. Lown B , Wolf M : Approaches to sudden death from coronary heart disease. Circulation 44:130-135, 1971.

12.

12. Robinson LA , Braimbridge MV , Hearse DJ : Creatine phosphate: An additive myocardial protective and antiarrhythmic agent in cardioplegia. J Thorac Cardiovasc Surg 87:190-200, 1984.

13.

13. Semenovsky MY , Shumakov VI , Zuckerman GI : Evaluation of the clinical use of phosphocreatine in cardiac surgery. In: Proceedings of the International Meeting on Phosphocreatine in Cardiology and Cardiac Surgery, pp 213-224, 1989.

14.

14. Robinson LA , Harwood DL : Exogenous creatine phosphate: Favourable calcium-altering effects in St. Thomas' Hospital Cardioplegic solution. J Am Coll Cardiol 11:170A-170A, 1988.

15.

15. Zucchi R , Poddighe R , Limbruno U : Protection of isolated rat heart from oxidative stress by exogenous CP. J Mol Cell Cardiol 21:67-73, 1983.

16.

16. Lemenev VL , Koshelev YM , Orlov GN : The use of phosphocreatine in vascular surgery for heart protection in patients with acute arterial occlusion (Pilot study). In: Proceedings of the International Meeting on Phosphocreatine in Cardiology and Cardiac Surgery, 1989, pp 269-277.